AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ICL Group Ltd.

Regulatory Filings Mar 8, 2018

6843_rns_2018-03-08_7573e77e-782a-4653-b1f2-e5f18c3d0eea.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

ICL Strategy

Hezi Israel, EVP BD & Strategy

מטפחים את ההווה. מפתחים את העתיד.

1

CULTIVATING THE PRESENT. DEVELOPING THE FUTURE.

Safe Harbor

This Presentation (references to which and to any information contained herein shall be deemed to include information which has been or may be supplied in writing or orally in connection herewith or in connection with any further enquiries) is provided for the sole purpose of providing general information to assist the recipient in deciding whether it wishes to proceed with a further investigation for investing in Israel Chemicals Ltd. and/or its affiliates (hereinafter jointly referred to as the "Company" or "ICL"). This Presentation shall not form the basis of, or be relied upon in connection with, any contract or commitment whatsoever, and it does not purport to be comprehensive or to contain all the information that the recipient may need in order to evaluate the Company and/or its assets .

No representation, warranty or undertaking, express or implied, is given by ICL and/or any member of the ICL Group or their respective directors, officers, employees, agents, representatives and/or advisers as to or in relation to the accuracy, completeness or sufficiency of the information contained in this Presentation or as to the reasonableness of any assumption contained therein. To the maximum extent permitted by law, the Company and its respective directors, officers, employees, agents, representatives and/or advisers expressly disclaim any and all liability which may arise from this Presentation and any errors contained therein and/or omissions therefrom or from any use of this Presentation or its contents or otherwise in connection therewith.

No representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on, any valuations, forecasts, estimates, opinions and projections contained in this Presentation. In all cases, recipients should conduct their own investigation of any analysis of the Company and/or its assets and the information contained in this Presentation. Nothing in this Presentation constitutes investment advice and any opinions or recommendations that may be contained herein have not been based upon a consideration of financial situation or particular needs of any specific recipient. Any prospective investor interested in buying Company's securities or evaluating the Company and/or its assets is recommended to seek its own financial and other professional advice.

This Presentation and/or other oral or written statements made by ICL during its presentation or from time to time, may contain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Whenever words such as "believe," "expect," "anticipate," "intend," "plan," "estimate", "predict" or similar expressions are used, the Company is making forward-looking statements. Such forward-looking statements may include, but are not limited to, those that discuss strategies, goals, financial outlooks, corporate initiatives, existing or new products, existing or new markets, operating efficiencies, or other non-historical matters .

These forward-looking statements and projections are not guarantees of future performance and are subject to a number of assumptions, risks, projections and uncertainties, many of which are beyond the Company's control, which could cause actual results, performance or achievements to differ materially from those described in or implied by such statements or projections. Because such statements deal with future events and are based on ICL's current expectations, they could be impacted or be subject to various risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in our Annual Report on Form 20-F for the year ended December 31, 2017, and in subsequent filings with the Tel Aviv Securities Exchange (TASE) and/or the U.S. Securities and Exchange Commission (SEC). Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can provide no assurance that expectations will be achieved. Except as otherwise required by law, ICL disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. Readers, listeners and viewers are cautioned to consider these risks and uncertainties and to not place undue reliance on such information.

Certain market and/or industry data used in this Presentation were obtained from internal estimates and studies, where appropriate, as well as from market research and publicly available information. Such information may include data obtained from sources believed to be reliable, however ICL disclaims the accuracy and completeness of such information which is not guaranteed. Internal estimates and studies, which we believe to be reliable, have not been independently verified. We cannot assure that such data is accurate or complete .

Included in this presentation are certain non-IFRS financial measures, such as Adjusted Operating income and Adjusted Net income, designed to complement the financial information presented in accordance with IFRS because management believes such measures are useful to investors. These non-IFRS financial measures should be considered only as supplemental to, and not superior to, financial measures provided in accordance with IFRS. Please refer to our Annual Report on Form 20-F for the year ended December 31, 2017 filed with TASE and the SEC for a reconciliation of the non-GAAP financial measures included in this presentation to the most directly comparable financial measures prepared in accordance with GAAP.

ICL TODAY

ICL Today

AGRICULTURE

Creating Value Along the Chain

Where do we want to go?

Our Strategic Guiding Principles

Upstream Vs. Downstream

  • Highly Capital Intensive
  • Volatile Market

UPSTREAM DOWNSTREAM

  • Successful track records in Phosphate & Bromine
  • Show greater cycle resilience
  • Higher ROI

OPTIMIZATION

IDENTIFY GROWTH OPPORTUNITIES

Our Strategic Focus

Our Strategic Focus

Optimization of our Mineral Assets

Operational Excellence In the Dead Sea and Rotem

  • Production process improvement
  • Early retirement plan
  • Rock production optimization
  • Energy efficiency
  • Maintenance optimization

ICL UK – full shift to Polysulphate in progress

  • ~ 50% reduction in workforce
  • Targeting 1M tonnes by 2020
  • Significant reduction in loss expected in 2018, profitability expected from 2020

ICL Iberia – mine consolidation & logistics upgrade

Building access ramp, expand capacity in Suria

15

New port terminal

YPH: Hub for Our Specialty Businesses in China

  • Significant reduction in operating loss in 2017
  • Operating break even expected in 2018
  • Accelerated shift towards specialty

Optimization

~10-15% ~5M Tonne

Reduction in potash cost per tonne over 5 Years

Maintain stable Potash production

Phosphate and UK to Specialty

Shift

Strong Market Position - A Robust base for Our Future

Highest concentration of Bromine in the World

Full phosphate chain from Rock to Salts: largest global merchant marketer of Purified Phosphoric acid

Variety of single, multi blends and agglomeration technology in food ingredients

Continuous Quest for Global Opportunities

  • Value over volume in phosphate specialties as done in the bromine value chain
  • Potential in China dilution of bromine resources and environmental regulation; grow WPA and salts
  • Drive innovation based on global trends
  • Bolt on acquisitions

Maintain strength. Provide stability.

Outgrow the market

Expand margins

Our Strategic Focus

Our Strategic Focus

Polysulphate as a Flagship of Our Semi-Specialty Business

A PREMIUM NICHE FERTILIZER WITH UNIQUE BENEFITS

From One Mineral to A World of Value Added Products

PK PluS Polysulphate NPK+Poly NPK+Micro NPS+Zinc NPS Potash Plus NPK + Coated PK PluS Polysulphate NP-APP SOP+ Poly NPK+Poly NPK+Micro NPS+Zinc NPS Potash Plus NPK + Coated PK PluS Polysulphate Granulated MOP NP-APP SOP+ Poly NPK+Poly NPK+Micro NPS+Zinc NPS Potash Plus NPK + Coated PK PluS Polysulphate Granulated MOP+Zinc Granulated MOP NP-APP SOP+ Poly NPK+Poly NPK+Micro NPS+Zinc NPS Potash Plus NPK + Coated PK PluS Polysulphate Polysulphate

2017

Growth

From ~\$100M to ~\$400M

Increase in Semi-Specialty sales within 5 years

Supportive Financial Position to Implement Our Strategy

* EBITDA is proforma of the divested businesses of Fire Safety and Oil Additives

** Calculated as: 2017 net debt - ~\$900M expected net proceeds from divestments

Cultivating the Present. Developing the Future.

ICL Specialty Fertilizers

Eli Amon, EVP Specialty Fertilizers

מטפחים את ההווה. מפתחים את העתיד.

31

CULTIVATING THE PRESENT. DEVELOPING THE FUTURE.

Our Strategic Focus

Our Core Markets and Products Today

6%

Global Trends Driving Shift Towards Specialty Fertilizers

Regulatory Pressure

Environmental Trends

Changing Food Chain

Population growth, urbanization & reduction in arable land per capita

36

New Grower Practices

Our Strengths

  • Leader in Key Markets
  • Access to P and K resources, unique access to Polysulphate
  • Wide Portfolio with well established brands & unique products

  • Profound agronomic knowledge & strong professional sales force

  • Advanced P and K chemistry
  • Advanced and flexible manufacturing technologies
  • Efficient Supply Chain

Leadership in Advanced Crop Nutrition Solutions

Our Goal

Leadership in Advanced Crop Nutrition Solutions

Innovate

Get closer to grower

Expand Valueadded product portfolio

Building Leadership in Advanced Crop Nutrition Solutions

Enhance Infrastructure and Business Developments

Leverage PrecisionAg to Grow sales

Digital Package to Enhance Sales

Remote sensing of nutrient deficiencies

Data analytics used to offer tailored products

Integration of data to an Ag platform

Mobile App

In-soil temperature sensor

Prescription tool: what fertilizer to apply when?

Growth through Leadership in Advanced Crop Nutrition

Create Over \$1BN Improve

best-in-class innovative platform Sales within 5 Years

Operating Margin

Cultivating the Present. Developing the Future.

מטפחים את ההווה. מפתחים את העתיד.

48

CULTIVATING THE PRESENT. DEVELOPING THE FUTURE.

ICL Strategy

Asher Grinbaum, Acting CEO

Our Path for Reshaping Our Strategy

Strategy Implementation

What to expect from ICL in the Future

Growth in Semi-Specialty

Growth through leadership in Advanced Crop Nutrition

Our Strategic Focus

Cultivating the Present. Developing the Future.

Appendix

* Before setoffs and inter-segment eliminations.

** Before G&A expenses. Before setoffs and inter-segment eliminations. All numbers are rounded.

ICL Specialty Solutions Profile

2017 MAIN FINANCIAL RESULTS

\$2.7BSALES* \$554MOPERATING INCOME**

% SALES BY BUSINESS UNIT

22% Food Specialties Industrial Products 45% Advanced Additives 33%

EMPLOYEES WORLDWIDE

* Before setoffs and eliminations ** Before G&A expenses All numbers are rounded

SPECIALTY SOLUTIONS SALES DISTRIBUTION

2017 PHOSPHATE VALUE CHAIN SALES*

ICL Specialty Fertilizers Profile

Talk to a Data Expert

Have a question? We'll get back to you promptly.